Display options
Cite
Mikamo H, Izumi K, Ito K, et al. Comparative study of the effectiveness of oral fluconazole and intravaginal clotrimazole in the treatment of vaginal candidiasis. Infect Dis Obstet Gynecol. 1995;3(1):7-11doi: 10.1155/S1064744995000238.
Mikamo, H., Izumi, K., Ito, K., & Tamaya, T. (1995). Comparative study of the effectiveness of oral fluconazole and intravaginal clotrimazole in the treatment of vaginal candidiasis. Infectious diseases in obstetrics and gynecology, 3(1), 7-11. https://doi.org/10.1155/S1064744995000238
Mikamo, H, et al. "Comparative study of the effectiveness of oral fluconazole and intravaginal clotrimazole in the treatment of vaginal candidiasis." Infectious diseases in obstetrics and gynecology vol. 3,1 (1995): 7-11. doi: https://doi.org/10.1155/S1064744995000238
Mikamo H, Izumi K, Ito K, Tamaya T. Comparative study of the effectiveness of oral fluconazole and intravaginal clotrimazole in the treatment of vaginal candidiasis. Infect Dis Obstet Gynecol. 1995;3(1):7-11. doi: 10.1155/S1064744995000238. PMID: 18475414; PMCID: PMC2364408.
Copy Download .nbib Format: NLM
Share it on

Infect Dis Obstet Gynecol. 1995;3(1):7-11. doi: 10.1155/S1064744995000238.

Comparative study of the effectiveness of oral fluconazole and intravaginal clotrimazole in the treatment of vaginal candidiasis.

Infectious diseases in obstetrics and gynecology

H Mikamo, K Izumi, K Ito, T Tamaya

Affiliations

  1. Department of Obstetrics and Gynecology School of Medicine Gifu University 40, Tsukasa-machi Gifu 5010, Japan.

PMID: 18475414 PMCID: PMC2364408 DOI: 10.1155/S1064744995000238

Abstract

OBJECTIVE: A study was carried out to compare 3 treatment regimens for vaginal candidiasis.

METHODS: A total of 150 women with clinical and mycological evidence of vaginal candidiasis were randomized to receive 50 mg of oral fluconazole daily for 6 days (50 women), a single oral 150 mg dose of fluconazole (50 women), or 100 mg of intravaginal clotrimazole daily for 6 days (50 women). They were assessed at 5-15 days (short-term assessment) and again at 30-60 days (long-term assessment) after the completion of treatment.

RESULTS: Candida species were completely eradicated from the vagina in 88% or 80% in the 6-day oral fluconzaole group, 76% or 70% in the single oral fluconazole group, and 72% or 60% in the intravaginal clotrimazole group at short-term or long-term assessment, respectively. The rates of clinical effectiveness were 92% or 88% in the 6-day oral fluconzaole group, 80% or 76% in the single oral fluconazole group, and 72% or 58% in the intravaginal clotrimazole group at the short-term or long-term assessment, respectively. Treatment-related side effects were not found in any group.

CONCLUSIONS: This study suggests that the treatment of vaginal candidiasis with oral fluconazole is effective and that a single oral fluconazole dose might be one choice in the treatment of vaginal candidiasis.

References

  1. Pharmacotherapy. 1984 Nov-Dec;4(6):343-73 - PubMed
  2. Br J Clin Pract. 1990 Jun;44(6):219-22 - PubMed
  3. Clin Exp Dermatol. 1982 Jul;7(4):345-54 - PubMed
  4. DICP. 1991 Jun;25(6):582-5 - PubMed
  5. JAMA. 1977 Oct 24;238(17):1836-7 - PubMed
  6. Antimicrob Agents Chemother. 1985 Dec;28(6):815-8 - PubMed
  7. Eur J Obstet Gynecol Reprod Biol. 1983 Mar;14(6):399-404 - PubMed
  8. Antimicrob Agents Chemother. 1985 May;27(5):832-5 - PubMed
  9. J Infect Dis. 1986 Aug;154(2):358-63 - PubMed
  10. Eur J Obstet Gynecol Reprod Biol. 1979 Aug;9(4):253-9 - PubMed
  11. Eur J Obstet Gynecol Reprod Biol. 1988 Dec;29(4):305-13 - PubMed
  12. Antimicrob Agents Chemother. 1985 Nov;28(5):648-53 - PubMed

Publication Types